Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study

0TipInsights

Authors

Peter Hillemanns•Michal Zikán14 more•Kristina Lindemann

Journal

Journal for ImmunoTherapy of Cancer

Published

January 1, 2025

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Oncology

Epidemiology

Immunology

Medicine

Internal Medicine

Show all topics

DOI

10.1136/jitc-2024-010827

License

cc-by-nc-nd